Atlas Trials

A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.

Clinical trial NCT00349336 · COMPLETED

Trial details

NCT number
NCT00349336
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2006-08-01
Primary completion
2008-11-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.